205 related articles for article (PubMed ID: 19463122)
1. [Rosuvastatin has no effect on clinical outcomes in patients with heart failure. Results of the GISSI-HF trial].
Preorazhenskiĭ DV
Kardiologiia; 2009; 49(4):64-5. PubMed ID: 19463122
[No Abstract] [Full Text] [Related]
2. [Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)].
Mareev VIu
Kardiologiia; 2008; 48(1):74-5. PubMed ID: 18261000
[No Abstract] [Full Text] [Related]
3. [The GISSI-HF trial].
Tavazzi L; Nodari S
G Ital Cardiol (Rome); 2009 Mar; 10(3):129-34. PubMed ID: 19385306
[No Abstract] [Full Text] [Related]
4. Atorvastatin, not rosuvastatin, improves cardiac function in heart failure: a meta-analysis of randomized trials.
Takagi H; Umemoto T
Int J Cardiol; 2012 Mar; 155(2):296-9. PubMed ID: 22200185
[No Abstract] [Full Text] [Related]
5. Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial.
Ghio S; Scelsi L; Latini R; Masson S; Eleuteri E; Palvarini M; Vriz O; Pasotti M; Gorini M; Marchioli R; Maggioni A; Tavazzi L;
Eur J Heart Fail; 2010 Dec; 12(12):1345-53. PubMed ID: 20952767
[TBL] [Abstract][Full Text] [Related]
6. Controlled Rosuvastatin Multinational Trial In Heart Failure (the positive negative trial).
Serebruany VL
Am J Cardiol; 2008 Jun; 101(12):1808-9. PubMed ID: 18549865
[No Abstract] [Full Text] [Related]
7. Going for gold, from Beijing to Munich, highlights from the ESC 2008 Congress: BEAUTIFUL, GISSI-HF, and potential new therapies for acute decompensated heart failure.
Kalra P; Pauriah M; Elder D; Lang CC
Cardiovasc Ther; 2008; 26(4):235-7. PubMed ID: 19035873
[No Abstract] [Full Text] [Related]
8. Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure.
Tavazzi L; Tognoni G; Franzosi MG; Latini R; Maggioni AP; Marchioli R; Nicolosi GL; Porcu M;
Eur J Heart Fail; 2004 Aug; 6(5):635-41. PubMed ID: 15302013
[TBL] [Abstract][Full Text] [Related]
9. [Rosuvastatin in patients with chronic heart failure].
Hoppe UC; Nitschmann S
Internist (Berl); 2009 Apr; 50(4):501-2. PubMed ID: 19300974
[No Abstract] [Full Text] [Related]
10. Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.
Abdul-Rahim AH; Perez AC; Fulton RL; Jhund PS; Latini R; Tognoni G; Wikstrand J; Kjekshus J; Lip GY; Maggioni AP; Tavazzi L; Lees KR; McMurray JJ; ;
Circulation; 2015 Apr; 131(17):1486-94; discussion 1494. PubMed ID: 25810334
[TBL] [Abstract][Full Text] [Related]
11. Rosuvastatin and cardiovascular continuum when time is important.
Barrios V; Escobar C
J Am Coll Cardiol; 2010 Apr; 55(15):1645-6; author reply 1646. PubMed ID: 20378088
[No Abstract] [Full Text] [Related]
12. Statin therapy in patients with heart failure and preserved left ventricular function.
Roik M
Circ J; 2009 Jul; 73(7):1359; author reply 1360. PubMed ID: 19556702
[No Abstract] [Full Text] [Related]
13. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.
Tavazzi L; Maggioni AP; Marchioli R; Barlera S; Franzosi MG; Latini R; Lucci D; Nicolosi GL; Porcu M; Tognoni G;
Lancet; 2008 Oct; 372(9645):1231-9. PubMed ID: 18757089
[TBL] [Abstract][Full Text] [Related]
14. International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction.
Kristensen SL; Køber L; Jhund PS; Solomon SD; Kjekshus J; McKelvie RS; Zile MR; Granger CB; Wikstrand J; Komajda M; Carson PE; Pfeffer MA; Swedberg K; Wedel H; Yusuf S; McMurray JJ
Circulation; 2015 Jan; 131(1):43-53. PubMed ID: 25406306
[TBL] [Abstract][Full Text] [Related]
15. Response to Letter Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.".
Abdul-Rahim AH; Perez AC; Fulton RL; Jhund PS; Latini R; Tognoni G; Wikstrand J; Kjekshus J; Lip GY; Maggioni AP; Tavazzi L; Lees KR; McMurray JJ
Circulation; 2015 Dec; 132(22):e358. PubMed ID: 26621661
[No Abstract] [Full Text] [Related]
16. Letter by Lin et al Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.".
Lin GM; Hung Y; Li YH
Circulation; 2015 Dec; 132(22):e357. PubMed ID: 26621660
[No Abstract] [Full Text] [Related]
17. CORONA, statins, and heart failure: who lost the crown?
Athyros VG; Kakafika AI; Tziomalos K; Karagiannis A; Mikhailidis DP
Angiology; 2008; 59(1):5-8. PubMed ID: 18319216
[No Abstract] [Full Text] [Related]
18. CCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI-HF trials.
Ueland T; Nymo SH; Latini R; McMurray JJ; Kjekshus J; Yndestad A; Fucili A; Grosu A; Masson S; Maggioni AP; Gullestad L; Aukrust P; ;
Eur J Heart Fail; 2013 Jul; 15(7):747-55. PubMed ID: 23487539
[TBL] [Abstract][Full Text] [Related]
19. Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials.
Latini R; Gullestad L; Masson S; Nymo SH; Ueland T; Cuccovillo I; Vårdal M; Bottazzi B; Mantovani A; Lucci D; Masuda N; Sudo Y; Wikstrand J; Tognoni G; Aukrust P; Tavazzi L;
Eur J Heart Fail; 2012 Sep; 14(9):992-9. PubMed ID: 22740508
[TBL] [Abstract][Full Text] [Related]
20. Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial.
Maggioni AP; Fabbri G; Lucci D; Marchioli R; Franzosi MG; Latini R; Nicolosi GL; Porcu M; Cosmi F; Stefanelli S; Tognoni G; Tavazzi L;
Eur Heart J; 2009 Oct; 30(19):2327-36. PubMed ID: 19717850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]